Atopic dermatitis
Conditions
Interventions
control group:Longmu Cream Formula
control group:placebo
Sponsors
Xiyuan Hospital of Chinese Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: (1) Comply with the Chinese and Western medical diagnostic criteria and evidence criteria of AD; (2) The degree of disease is mild to moderate patients; (3) Aged 6-12 years old; (4) Patients or their guardians signed the informed consent and had good compliance.
Exclusion criteria
Exclusion criteria: (1) Have received AD-related topical, oral, or systemic therapy, such as topical calcineurin inhibition, within one week; (2) Abnormal liver or kidney function (ALT, AST greater than 1.5 times, BUN, Cr greater than 1 times) or suffering from other other serious diseases; (3) Combination of other dermatological diseases that affect the judgement of the severity of the disease; (4) Known history of allergy to the test drugs (drugs in Longmu Cream Formula); (5) Patients who are also participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| eczema area and severity index; | — |
Secondary
| Measure | Time frame |
|---|---|
| peak pruritus numerical rating scale;the Children’s dermatology life quality index;patient-oriented eczema measure;RECAP of atopic eczema;Inflammatory indicators;Histological index; | — |
Countries
China
Contacts
Public ContactLang Na
Xiyuan Hospital of Chinese Academy of Traditional Chinese Medicine
Outcome results
None listed